Real‐world experience of secukinumab in moderate to severe psoriasis patients in Thailand: Characteristics, effectiveness, and safety

Secukinumab demonstrated high efficacy and favorable safety profile in patients with moderate‐to‐severe plaque psoriasis (PsO) in clinical trials. However, understanding of patient characteristics and clinical outcomes in real world in Thailand is still limited. To describe patient characteristics,...

Descripción completa

Detalles Bibliográficos
Autores principales: Asawanonda, Pravit, Pattamadilok, Bensachee, Chularojanamontri, Leena, Chuamanochan, Mati, Choonhakarn, Charoen, Chakkavittumrong, Panlop, Sangob, Naruemon, Rajatanavin, Natta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078165/
https://www.ncbi.nlm.nih.gov/pubmed/36279306
http://dx.doi.org/10.1111/dth.15958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078165/
https://www.ncbi.nlm.nih.gov/pubmed/36279306
http://dx.doi.org/10.1111/dth.15958

Ejemplares similares